Acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after administration of arsenic trioxide for acute promyelocytic leukemia
Authors:
- 15 May 2008
- journal article
- case report
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 65 (10) , 941-946
Abstract
Purpose. The case of a patient who developed acute renal failure, gastrointestinal bleeding, and cardiac arrhythmia after receiving arsenic trioxide for the treatment of acute promyelocytic leukemia (APL) is described.Keywords
This publication has 34 references indexed in Scilit:
- Arsenic Trioxide Therapy in Relapsed or Refractory Japanese Patients with Acute Promyelocytic Leukemia: Updated Outcomes of the Phase II Study and Postremission TherapiesInternational Journal of Hematology, 2005
- Arsenic in cancer therapyAnti-Cancer Drugs, 2005
- An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low‐dose all‐trans retinoic acidHematological Oncology, 2004
- Arsenic Speciation in Urine from Acute Promyelocytic Leukemia Patients undergoing Arsenic Trioxide TreatmentChemical Research in Toxicology, 2003
- Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemiaCancer, 2003
- Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoringLeukemia, 2002
- Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic LeukemiaAnnals of Internal Medicine, 2000
- Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemiaBritish Journal of Haematology, 1998
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981